We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product name
Octadecanedioic acid;
1,16-Dicarboxyhexadecane;
1,16-Hexadecanedicarboxylic acid;
1,18-Octadecanedioic acid;
Emerox 118;
Semaglutide intermediate
CAS No.
871-70-5
Molecular Formula
C18H34O4
Molecular Weight
314.466
Molecular Structure
Quality Standard
98% up by HPLC
Appearance
White or off-white powder
ANALYSIS
SPECIFICATION
RESULTS
Appearance
White or off-white powder
Conforms
DC16
< 0.2%
0.12%
DC20
< 0.2%
ND
Purity (by HPLC)
≥ 98.0%
99.6%
Conclusion
The product meets enterprise standard
CDMO service: We can customized manufacturing according to your requirement.
What is Octadecanedioic acid?
Octadecanedioic acid is one of key intermediates of Semaglutide. Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control. Side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.
Twenty years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
